Effect of agitation on the peptide fibrillization: Alzheimer's amyloid-β peptide 1-42 but not amylin and insulin fibrils can grow under quiescent conditions

Journal of Peptide Science

Volumn 19, Issue 6, 2013, Pages 386-391

  Tiiman, Ann ^a   Noormägi, Andra ^a,b   Friedemann, Merlin ^a   Krishtal, Jekaterina ^a   Palumaa, Peep ^a,b   Tõugu, Vello ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b Competence Center on Reproductive Medicine and Biology ^*  (Estonia)

Author keywords

Agitation; Alzheimer's amyloid ; Amylin; Fibrillization; Insulin

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN[1-42]; INSULIN;

AGITATION; ALZHEIMER DISEASE; ARTICLE; FIBER; GROWTH CURVE; IN VITRO STUDY; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; INSULIN; ISLET AMYLOID POLYPEPTIDE; PEPTIDE FRAGMENTS;

EID: 84877718000     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2513     Document Type: Article

References (26)

1. Harrison RS, Sharpe PC, Singh Y, Fairlie DP. Amyloid peptides and proteins in review. Rev. Physiol. Biochem. Pharmacol. 2007; 159: 1-77.
2. Dobson CM. Protein folding and misfolding. Nature 2003; 426(6968): 884-90.
3. Harper JD, Lansbury PT, Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 1997; 66: 385-407.
4. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA 1996; 93(3): 1125-1129.
5. Knowles TPJ, Waudby CA, Devlin GL, Cohen SIA, Aguzzi A, Vendruscolo M, Terentjev EM, Welland ME, Dobson CM. An analytical solution to the kinetics of breakable filament assembly. Science 2009; 326(5959): 1533-1537.
6. Dunstan DE, Hamilton-Brown P, Asimakis P, Ducker W, Bertolini J. Shear flow promotes amyloid-{beta} fibrilization. Protein Eng. Des. Sel. 2009; 22(12): 741-746.
7. Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: pathways, induction factors and analysis. J. Pharm. Sci. 2009; 98(9): 2909-2934.
8. Morinaga A, Hasegawa K, Nomura R, Ookoshi T, Ozawa D, Goto Y, Yamada M, Naiki H. Critical role of interfaces and agitation on the nucleation of abeta amyloid fibrils at low concentrations of abeta monomers. Biochim. Biophys. Acta 2010; 1804(4): 986-95.
9. Stine WB, Jr., Dahlgren KN, Krafft GA, LaDu MJ. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 2003; 278(13): 11612-22.
10. Wiltfang J, Smirnov A, Schnierstein B, Kelemen G, Matthies U, Klafki HW, Staufenbiel M, Hüther G, Rüther E, Kornhuber J. Improved electrophoretic separation and immunoblotting of beta-amyloid (a beta) peptides 1-40, 1-42, and 1-43. Electrophoresis 1997; 18(3-4): 527-32.
11. Dunn M. Detection of proteins in polyacrylamide gels by silver staining. In The Protein Protocols Handbook, Walker J (ed.). Humana Press, New York, 1996; 229-233.
12. Tõugu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, Palumaa P. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J. Neurochem. 2009; 110(6): 1784-95.
13. Nielsen L, Frokjaer S, Brange J, Uversky VN, Fink AL. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 2001; 40(28): 8397-409.
14. Zovo K, Helk E, Karafin A, Tougu V, Palumaa P. Label-free high-throughput screening assay for inhibitors of Alzheimer's amyloid-beta peptide aggregation based on MALDI MS. Anal. Chem. 2010; 82(20): 8558-8565.
15. Hamilton-Brown P, Bekard I, Ducker WA, Dunstan DE. How does shear affect a beta fibrillogenesis? J. Phys. Chem. B 2008; 112(51): 16249-16252.
16. Noormägi A, Gavrilova J, Smirnova J, Tõugu V, Palumaa P. Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin. Biochem. J. 2010; 430: 511-518.
17. Hofrichter J. Kinetics of sickle hemoglobin polymerization. III. Nucleation rates determined from stochastic fluctuations in polymerization progress curves. J. Mol. Biol. 1986; 189(3): 553-71.
18. Larson JL, Miranker AD. The mechanism of insulin action on islet amyloid polypeptide fiber formation. J. Mol. Biol. 2004; 335(1): 221-231.
19. Librizzi F, Rischel C. The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways. Protein Sci. 2005; 14(12): 3129-34.
20. Padrick SB, Miranker AD. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 2002; 41(14): 4694-703.
21. Hellstrand E, Boland B, Walsh DM, Linse S. Amyloid beta-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem. Neurosci. 2010; 1(1): 13-18.
22. Karafin A, Palumaa P, Tõugu V. Monitoring of amyloid-beta fibrillization using an improved fluorimetric method. In New Trends in Alzheimer and Parkinson Related Disorders: ADPD 2009, Fisher A, Hanin I (eds). Medimond International Proceedengs: Bologna, Italy, 2009; 255-261.
23. Sarell CJ, Wilkinson SR, Viles JH. Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-beta from Alzheimer disease. J. Biol. Chem. 2010; 285(53): 41533-41540.
24. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE. Rapid induction of Alzheimer a beta amyloid formation by zinc. Science 1994; 265(5177): 1464-7.
25. Murray IV, Liu L, Komatsu H, Uryu K, Xiao G, Lawson JA, Axelsen PH. Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J. Biol. Chem. 2007; 282(13): 9335-45.
26. Kellermayer MS, Karsai A, Benke M, Soos K, Penke B. Stepwise dynamics of epitaxially growing single amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 2008; 105(1): 141-4.